Study Title: A Randomized Phase II/III Study of Docetaxel and Ramucirumab with or Without Cemiplimab (REGN2810) for Participants Previously Treated with Platinum-based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
For more information about the trial above please contact the study team:Medical University of South CarolinaAffiliate Principal Investigator, Lupak, Oleksandra, at oll203@musc.edu.Principal Investigator, Rangel, Christopher, at rangelc@musc.edu.Study Coordinator, Morgan, Shelby, at morshelb@musc.edu.Ralph H. Johnson VAMCStudy Coordinator, Jeter, Kathy, at katherine.jeter2@va.gov.Trial opened at the following institutions: Ralph H. Johnson VAMC, Medical University of South Carolina